NVIDIA’s finance team has walked back CEO Jensen Huang’s $500 billion revenue projection for Blackwell and Rubin AI chips. The corrected figure reveals important context about NVIDIA’s actual growth trajectory and market position.
Character.ai will ban teenagers from chatbot conversations starting November 25 following lawsuits and safety concerns. Meanwhile, Nvidia’s market value surpasses $5 trillion as the AI boom continues reshaping technology markets and regulations.
Balance has introduced an AI communication protocol that connects large language models with B2B payment systems. The technology promises to revolutionize how businesses handle transactions through natural language interfaces. This represents a significant step toward autonomous B2B commerce.
Multi-agent AI systems are transforming medical research and diagnosis. Google DeepMind’s approach uses teams of AI agents that collaborate for weeks to solve complex problems that previously took human researchers years.
A groundbreaking clinical trial during the pandemic revealed that traditional data verification methods may be obsolete. Automated systems proved 99.7% accurate, potentially transforming how medical research is conducted worldwide.
Character.AI’s decision to restrict teen access to open-ended chats represents a watershed moment for AI safety. The move reflects growing regulatory pressure and concerns about AI’s psychological impact on young users.
In a surprising strategic pivot, Grammarly is rebranding to Superhuman following its July acquisition. The company is launching an AI assistant that integrates with productivity tools while maintaining its core writing product.
A landmark study of 40,425 breast tumors reveals significant differences in cancer genetics across ancestral groups. These findings could reshape precision medicine approaches and address longstanding health disparities in cancer care.
A comprehensive analysis of clinical trial data reveals new insights into drug development success rates. The study standardized data from 20,398 drug development programs across 9,682 unique molecular entities.
Researchers have developed quantum lattice gates that could revolutionize bosonic quantum computing. These gates operate in under one nanosecond, dramatically faster than existing approaches while utilizing the full nonlinearity of superconducting circuits.
